Abstract Increased oxidative stress is associated with type-2 diabetes and related cardiovascular diseases, but oxidative modification of LDL has been partially characterized. Our aim was to compare the lipid and fatty acid composition as well as the redox status of LDL from diabetic patients and healthy subjects. First, to ensure that isolation of LDL by sequential ultracentrifugation did not result in lipid modifications, lipid composition and peroxide content were determined in LDL isolated either by ultracentrifugation or fast-protein liquid chromatography. Both methods resulted in similar concentrations of lipids, fatty acids, hydroxy-octadecadienoic acid (HODE) and malondialdehyde (MDA). Then, LDLs were isolated by ultracentrifugation from eight type-2 diabetic patients and eight control subjects. Compared to control LDL, diabetic LDL contained decreased cholesteryl esters and increased triglyceride concentrations. Ethanolamine plasmalogens decreased by 49%. Proportions of linoleic acid decreased in all lipid classes, while proportions of arachidonic acid increased in cholesteryl esters. Total HODE concentrations increased by 56%, 12-and 15-hydroxy-eicosatetraenoic acid by 161 and 86%, respectively, and MDA levels increased by twofold. a-Tocopherol concentrations, expressed relative to triglycerides, were lower in LDL from patients compared to controls, while c-tocopherol did not differ. Overall, LDL from type-2 diabetic patients displayed increased oxidative stress. Determination of hydroxylated fatty acids and ethanolamine plasmalogen depletion could be especially relevant in diabetes. 
Introduction
Type-2 diabetes is associated with an increased risk for atherosclerosis. There is strong evidence that oxidative stress plays a key role in the onset of diabetes [1] and in the development of vascular complications of the disease [2] . Low-density lipoproteins (LDL) are important targets of oxidation, and oxidative modification of LDL is involved in the pathogenesis of atherosclerosis [3] . Oxidative stress has been mostly assessed in plasma from diabetic patients, which showed increased concentrations of thiobarbituric acid-reactive species (TBARS) [4] and isoprostanes [5] , both end-products of lipid peroxidation. Evidence for increased oxidative stress in LDL from type-2 diabetic patients is indirect, mostly based on increased plasma levels of autoantibodies against oxidatively modified LDL [6] . More data on specific parameters of LDL oxidation are therefore needed and could be useful to define predictive biomarkers for cardiovascular risk.
The aim of this study was to assess oxidative stress specifically in LDL from type-2 diabetic patients compared to LDL from healthy subjects. First, we compared the lipid composition and redox status of LDL isolated by the conventional sequential flotation ultracentrifugation (UC) to that of LDL separated by fast-protein liquid chromatography (FPLC) in order to check if isolation of LDL by UC did not lead to artifactual oxidation of the particles, as previously suggested [7] . Then, we performed detailed analysis of lipid classes including fatty acids and different complementary markers of lipid peroxidation in diabetic and control LDL.
Materials and Methods

Blood Collection
Regarding the comparative study of LDL separated by UC or FPLC, venous blood from three healthy blood donors (33 ± 13 years) was collected on citrate phosphate dextrose (citrate 15.6 mM, sodium citrate 89.4 mM, monosodic phosphate 16.1 mM, dextrose 128.7 mM, pH 5.6, one volume for seven volumes of blood) as an anticoagulant. Plasma was immediately separated by centrifugation at 1,500g for 10 min and spiked with 1 mM EDTA and 10 lM butylhydroxytoluene (BHT).
Regarding the clinical study, type-2 diabetic patients (8 men, aged 59 ± 2 years) recruited in the Department of Endocrinology and Metabolic Diseases (HCL Lyon) were matched for sex and age to healthy subjects (8 men, aged 51 ± 4 years). Exclusion criteria were smoking, antioxidant/vitamin supplementation, anti-aggregatory drugs and insulin treatment. Hypolipidemic drug (statins and fibrates) treatment was suspended for 7 days before venipuncture. Control subjects were in good health as assessed by medical history, and exclusion criteria were any pathology including diabetes. Written informed consent was obtained from all participants, and the study was approved by the local ethics committee (CCP Sud Est IV). Plasma was separated by centrifugation at 1,500g for 10 min of blood collected on EDTA; 10 lM BHT was added to plasma, which was immediately frozen at -80°C under nitrogen for further characterizations.
LDL Isolation by Ultracentrifugation
LDLs (density 1.019-1.063) were separated from plasma by potassium bromide stepwise UC. UC was carried out in a TLA 100.3 fixed-angle rotor of a Beckman TL-100 table top UC (Beckman Coulter France, Roissy CDG, France). The LDL fraction was dialyzed extensively against phosphate buffered saline (NaCl 136.8 mM, KCl 2.6 mM, KH 2 PO 4 1.71 mM, Na 2 HPO 4 , 12H 2 O 8 mM, pH 7.2) containing 1 mM EDTA.
LDL Isolation by FPLC
LDLs were isolated from plasma by gel filtration chromatography at 4°C as previously described [8] and modified as follows [9] . Briefly, a BioRad System FPLC (Bio-Rad Laboratories, Marnes-la-Coquette, France) equipped with a Superose 6 HR 10/30 column (GE Healthcare Europe GmbH, Munich, Germany) was used with 10 mM Tris-HCl, 150 mM NaCl, pH 7.4 buffer containing 2 mM EDTA and 0.02% sodium azide as a running buffer. After loading filtered plasma, chromatography was carried out with a flow rate of 0.3 ml/min under a pressure of 150 psi. Fractions of 0.3 ml were collected, and the concentrations of triglycerides (TG) and total cholesterol in the eluted fractions were measured (BioMérieux, Marcy l'Etoile, France). LDL fractions were concentrated on a Millipore filter of 30,000 MW (10 min at 4,000g).
Protein, Total LDL Cholesterol and Triacylglycerol Determinations
Colorimetric determination of protein concentration was processed according to the modified Lowry method [10] . Enzymatic determination of total cholesterol and TG were processed using commercial kits (BioMérieux, Marcy l'Etoile, France).
LDL Cholesterol Determination
Lipid classes were separated by HPLC coupled to an Evaporative Light Scattering Detector (ELSD) according to the modified method of Seppanen-Laakso [11] .
Fatty Acid Composition of LDL Lipid Classes
After the addition of appropriate internal standards (1,2-diheptadecanoyl-sn-glycero-3-phosphocholine, 1,2-diheptadecanoyl-sn-glycero-3-phosphoethanolamine, 1,2,3-triheptadecanoyl-sn-glycerol and heptadecanoyl cholesteryl ester), total LDL lipids were extracted twice by the addition of ethanol (3 vol) and chloroform (6 vol) in the presence of BHT (50 lM). Lipid classes were then separated by thin-layer chromatography. The first solvent mixture chloroform/methanol (80:8, v/v) allowed us to separate neutral lipids from phospholipids (PL). The second solvent mixture chloroform/methanol/water (63:27:4, by vol.) separated phosphatidylcholines (PC), ethanolamine phospholipids (Etn-PL) and sphingomyelins (SM). Neutral lipids were separated in TG and cholesteryl esters (CE) by a second thin-layer chromatography using hexane/diethylether/acetic acid (80:20:1, by vol.) as solvent. The different spots were scrapped off, treated with trifluoride boron/ methanol (1:1, v/v) for 90 min at 100°C. The derivatized fatty acid methyl esters were then extracted twice with isooctane and separated by GLC, using an HP 6890 gas chromatograph equipped with a SP 2380 capillary column (0.25 lm, 30 m 9 0.25 mm, Supelco, Bellefonte, PA).
Quantification of Total LDL Monohydroxylated Fatty Acids
Following the lipid extraction as described above, dried extracts were subjected to ethanolic hydrolysis with 10 M KOH for 20 min at 60°C [12] . No reduction of lipid hydroperoxides was carried out. Non-esterified hydroxylated fatty acids and fatty acids were first separated on an Oasis Sep-Pak cartridge column (Waters, Milford, MA). The column was activated with 6 ml of methanol and 6 ml of water before loading the sample. Then, it was washed with 8 ml of 2% NH 4 OH water and 8 ml of methanol.
Products were eluted with 8 ml of acetonitrile/2-propanol (60:40, v/v) containing 5% formic acid. Non-esterified hydroxylated fatty acids were secondly separated by thinlayer chromatography with hexane/diethylether/acetic acid (60:40:1, by vol.) as mobile phase and extracted from silica with methanol. Then, hydroxylated fatty acids were separated by reverse phase-HPLC on X Bridge C 18 column (3.5 lm, 4.6 9 150 mm column, Waters, Milford, MA) using a gradient solvent of acetonitrile and water (pH 3) and detected at 235 nm.
Malondialdehyde Determination in LDL
Malondialdehyde (MDA) concentration was determined by RP-HPLC according to the method of Therasse and Lemonnier [13] . LDL samples, mixed with thiobarbituric acid (TBA) (10 mM), acetic acid and BHT (5 mM), were heated for 60 min at 95°C. The TBA-MDA adducts were then extracted with ethyl acetate and separated onto a Nucleosil C 18 column (5 lm, 4.6 9 250 mm, MachereyNagel, Hoerdt, France) using methanol/water (20:80, v/v) as mobile phase. Detection was performed by fluorimetry (excitation 515 nm, emission 553 nm).
Vitamin E Determination in LDL and Plasma
Tocopherol concentrations were determined by RP-HPLC [14] . Tocopherols were first extracted from LDL and plasma (1 vol) twice with hexane (4 vol) after the addition of ethanol (1 vol). Then, they were separated onto a Nucleosil C 18 column (5 lm, 4 9 150 mm, Macherey-Nagel, Hoerdt, France) using methanol/water (98:2, v/v) as mobile phase. Detection was performed by fluorimetry (excitation 295 nm, emission 340 nm) and quantification was allowed by the addition of tocol as an internal standard.
Statistical Analysis
Results are expressed as the mean ± SEM. Comparisons between groups were performed using a non-parameter Mann-Whitney test. Statistical significance was established at p B 0.05. Correlation coefficients were determined using linear regression analysis.
Results
Comparison of LDL Isolated by Ultracentrifugation and Fast-Protein Liquid Chromatography
In order to determine whether isolation of LDL by UC generated LDL with a lipid composition and lipid redox status comparable to those issued from FPLC separation, fresh plasma samples from healthy volunteers were subjected in parallel to the two procedures. There were no differences between lipid composition in LDL either separated by UC or FPLC. As expected, CE was the major lipid class in LDL (51%) followed by cholesterol (29%) and few TG (3.4%). PCs were the major phospholipids present in LDL (11%) (data not shown).
The GLC analysis of fatty acid methylesters derived from Etn-PL allowed us to determine the fatty dimethylacetals (DMA) representative of alkeny,acyl-GPE (or PE plasmalogens), a subclass particularly sensitive to oxidative stress. No difference in total DMA concentrations was found between both methods of isolation (6.1 ± 1.7 nmol/mg protein in LDL isolated by UC vs. 4.6 ± 2.9 nmol/mg protein in LDL isolated by FPLC) representing 15.8 ± 4.6% vs. 12.5 ± 8% total fatty acids in Etn-PL, respectively.
The concentrations of linoleic acid (18:2n-6), the most abundant polyunsaturated fatty acid (PUFA) and substrate for lipid peroxidation, were similar in LDL either isolated by UC or FPLC (1,638 ± 44 vs. 1,543 ± 17 nmol/mg protein). As shown in Table 1 , the stable primary products issued from the peroxidation of 18:2n-6, 9-hydroxyoctadecadienoic acid (HODE) and 13-HODE represented 0.05% of the parent molecule and were present in similar concentrations regardless of the LDL isolation method. The ratio of total HODEs to its parent fatty acid was also similar in LDL isolated by UC or FPLC. One of the aldehydes arising from the decomposition of fatty acid hydroperoxides, MDA, was found to be formed in similar amounts in LDL either separated by UC or FPLC. Concerning the main antioxidants, a-and c-tocopherol were present in similar concentrations in LDL isolated by either method. Overall, the lipid composition and the redox status were similar whatever the LDL separation method.
Lipid Composition and Redox Status of LDL from Diabetic Patients Compared to LDL from Healthy Subjects
Clinical Characteristics
Type-2 diabetic patients (n = 8) had poorly controlled diabetes as shown by elevated values of glycated hemoglobin HbA 1c (10.6 ± 0.9%) and glycemia (9.2 ± 1.3 mM) compared to healthy volunteers (5.4 ± 0.1% and 5.6 ± 0.2 mM, respectively, n = 8). They presented a metabolic syndrome as assessed by their large waist circumference of 118.1 ± 8.4 cm, elevated TG of 2.5 ± 0.2 mM and low HDL-cholesterol of 0.9 ± 0.1 mM [15] . Sex-and age-matched healthy volunteers had values of waist circumference (91.3 ± 1.7 cm), TG (1.3 ± 0.1 mM) and HDL-cholesterol (1.4 ± 0.1 mM) in the expected normal range.
Lipid and Fatty Acid Compositions of Diabetic LDL Compared to Control LDL
The concentrations of main lipid classes were determined in LDL from type-2 diabetic patients and healthy subjects ( Table 2) . In diabetic LDL, the concentration of CE, the main LDL lipid class, decreased by 21%, whereas concentrations of TG increased by 75%. No changes in cholesterol, PC and Etn-PL concentrations were observed between the two groups.
The fatty acid composition of the main LDL lipid classes, namely CE and PC, showed several differences between diabetic patients and control subjects. As shown in Table 3 , PUFA represented 62% of the total fatty acids in CE from control LDL, and their proportion significantly decreased in diabetic LDL. In particular, 18:2n-6, the main PUFA, decreased, whether expressed in mole percent (-11%) or in nmol/mg protein (-30%). Arachidonic acid Values represent means ± SEM of at least six determinations per group * p B 0.05 and ** p B 0.01 compared with healthy subjects (20:4n-6) proportion significantly increased by 43% in diabetic LDL, unlike its concentration. An increase in saturated fatty acid (SFA) proportion was observed, while the monounsaturated fatty acid (MUFA) proportion was unchanged between the two groups (Table 3) . Concerning PC, the main PL class, lower proportions and concentrations of the major fatty acid 18:2n-6 (-12 and -17%, respectively) were present in diabetic LDL compared to control LDL, while the proportion of 20:4n-6 tended to increase. No significant changes of SFA and MUFA were observed (Table 4 ). In Etn-PL including the PE plasmalogen subclass, DMA represented 22.9% of the total fatty chains present in Etn-PL from control LDL and only 11.8% of those in PE from diabetic LDL. The 49% decrease reflected a significant decrease of each DMA species, namely 16:0, 18:0 and 18:1n-9 DMA produced by transmethylation of the sn-1 position of plasmalogens (Fig. 1) . The sum of DMA species negatively correlated with HbA 1c % (r 2 = 0.61, p \ 0.001).
Lipid Peroxide and Antioxidant Content of Diabetic LDL Compared To Controls
The concentrations of total (both free and esterified) hydroxylated fatty acids, the stable primary products of non-enzymatic peroxidation of PUFA, were assessed in LDL from patients and control groups. As shown in Table 5 , 9-HODE and 13-HODE, derived from 18:2n-6, were detected, and their concentrations significantly increased by 49 and 44%, respectively. In addition, the ratio of total HODE to its parent fatty acid increased by 58% in diabetic LDL. Among hydroxy-eicosatetraenoic acids (HETE) derived from 20:4n-6, 8-, 11-, 12-and 15-HETE were detected in LDL from each volunteer, but not a-Tocopherol concentrations in LDL did not differ between patients and controls when expressed per mg cholesterol (3.47 ± 0.43 vs. 2.79 ± 0.24 nmol/mg cholesterol). However, when expressed relative to TG, a-tocopherol levels significantly decreased by 32% in LDL from diabetic patients compared to control subjects (14.3 ± 1.1 vs. 21.2 ± 2.5 nmol/mg TG, p \ 0.05). c-Tocopherol did not significantly change in diabetic LDL compared to control LDL when expressed per mg cholesterol (0.46 ± 0.08 vs. 0.29 ± 0.06 nmol/mg cholesterol) or per mg TG (1.8 ± 0.3 vs. 2.3 ± 0.5 nmol/mg TG). In plasma, a-tocopherol concentrations did not differ between diabetic patients and control subjects (12.2 ± 1.2 vs. 11.9 ± 1.2 lmol/l). The concentrations of plasma a-tocopherol in patients (5.4 ± 0.5 mmol/mol TG) were significantly lower than concentrations in controls (9.8 ± 0.7 mmol/mol TG) when expressed relative to TG, but not when expressed relative to cholesterol (2.8 ± 0.5 vs. 2.0 ± 0.2 mmol/mol cholesterol). c-Tocopherol concentrations were similar in plasma from diabetic patients and controls (1.7 ± 0.3 vs. 1.6 ± 0.4 lmol/l) and whether expressed relative to cholesterol (0.41 ± 0.10 vs. 0.25 ± 0.06 mmol/mol cholesterol) or TG (0.68 ± 0.09 vs. 1.22 ± 0.21 mmol/mol TG).
Discussion
In the present study, we first compared LDL isolated by UC to those isolated by FPLC in order to use a method expected to minimize the artifactual oxidative modification of the particles during processing. It has indeed been suggested that conventional UC may cause structural changes in lipoproteins, whereas FPLC does not affect lipoprotein structure [7] . Our results show that the isolation of lipoproteins by UC or FPLC results in similar concentrations of lipids, fatty acid proportions and lipid peroxide content in LDL. Proportions of lipid classes were equivalent in LDL isolated by either method and close to those reported in the literature [16, 17] . Concentrations of PE plasmalogens particularly prone to oxidation [18] were similar in LDL, whatever the method of isolation, suggesting that the procedure of UC and dialysis was not more damaging than FPLC.
Regarding the substrates for lipid peroxidation in LDL isolated by UC, total concentrations of PUFA were 2,074 nmol/mg protein, including 1,638 nmol/mg protein of 18:2n-6, in good agreement with published data [19, 20] . Similar concentrations were obtained after FPLC isolation of LDL (1,961 nmol/mg protein PUFA including 1,543 nmol/mg protein 18:2n-6), indicating that PUFAs were not more autooxidized in LDL separated by UC and further dialyzed. In accordance with the PUFA composition of LDL, very little peroxidation of PUFA occurred in LDL from healthy volunteers since hydroxylated derivatives of 18:2n-6 (9-and 13-HODE) represented 0.05% of the parent molecule, whatever the method of LDL isolation. Finally, concentrations of MDA, commonly used as an index of overall lipid peroxidation, and of tocopherol isomers, the main LDL antioxidants, were similar in LDL either isolated by UC and FPLC. This rules out a loss of Values are means ± SEM of seven subjects per group * p B 0.05 and ** p B 0.01 compared with LDL from healthy subjects HETE hydroxy-eicosatetraenoic acid, HODE hydroxy-octadecadienoic acid MDA and vitamin E during the dialysis process following UC, as previously reported [21, 22] . As separation of lipoproteins by UC led to LDL particles with lipid and lipid peroxide contents comparable to those issued from FPLC, UC was used to determine the profile of LDL from type-2 diabetic patients compared to that of LDL from healthy subjects.
Although there is evidence of increased oxidative stress in type-2 diabetes, it has been mainly based to date on the measurement of a single biomarker, not reflecting the overall oxidative damage. In addition, oxidative stress has been mostly assessed in plasma [23] and not in LDL. We provide evidence that LDL from type-2 diabetic patients displayed increased oxidative stress compared to LDL from healthy volunteers. First, diabetic LDL showed increased TG and decreased CE. Such a modified lipid composition may reflect a higher percentage of small dense LDLs, which are known to be more prevalent in type-2 diabetes [24, 25] . It has indeed been shown that small, dense, TG-rich LDL particles are subjected to exchange processes that remove CE from the core and replace it with TG [26, 27] , and are more susceptible to oxidation [28] . To identify original markers of oxidative stress in LDL from diabetic patients, different complementary indices representative of different steps in the lipid peroxidation process were assessed. We show that PE plasmalogens decreased by 49% in diabetic LDL compared to control LDL. Plasmalogens were shown to contribute to the oxidation resistance of LDL and can serve as endogenous antioxidants in situ and in vitro [18, 29] . Loss of plasmalogens in LDL could represent a marker of oxidative stress in diabetic patients. In addition, plasmalogens have been involved in many diseases [30] , but to our knowledge, this is the first evidence for decreased concentrations of plasmalogens in type 2 diabetes.
Since 18:2n-6 and 20:4n-6 are the main PUFA in LDL, their stable primary products of peroxidation, HODE and HETE, were determined as well as the ratio of oxidation product to parent fatty acids, described as a biomarker of oxidation status of LDL [31] . We show for the first time that both free and esterified HODE, representing 0.04% of the parent molecule in control LDL, increased by 49% in LDL from diabetic patients. This reflects free radical peroxidation of 18:2n-6 and is in line with the decrease of 18:2n-6 in the PUFA-rich, lipid classes, CE and PC. Consequently, the HODE to 18:2n-6 ratio was significantly higher (?58%) in diabetic LDL than in control LDL. Because of the lack of appropriate standards, we could not confirm the presence of trans,trans-HODE stereoisomers as shown in plasma [32, 33] , but cannot exclude them. Total HETE represented 0.08% of the parent molecule in control LDL, indicating that 20:4n-6 is more susceptible to oxidation. 12-and 15-HETE increased by 161 and 86% in diabetic LDL, while 8-and 11-HETE tended to increase. However, there was no significant increase of the HETE to 20:4n-6 ratio due in part to the increased proportion of 20:4n-6 in CE. This paradoxical increase of 20:4n-6 cannot be explained from the present investigation, but might result from exacerbation of D6 and D5 desaturase activities in type-2 diabetes leading to increased production of 20:4n-6 from 18:2n-6. As insulin activates both enzymes [34] , this situation may occur in type-2 diabetes, which is associated with chronic hyperinsulinemia periods. Finally, increased lipid peroxidation in LDL from diabetic patients compared to control LDL was confirmed by twofold increased concentrations of MDA. This is in agreement with previously reported increased levels of serum lipid peroxides, measured as thiobarbituric acid-reactive substances, in plasma from patients suffering from diabetes [4, 35] . Regarding the main lipid-soluble antioxidant in LDL, a-tocopherol, its concentration was significantly lower in LDL from diabetic patients compared to control LDL when expressed relative to TG, but not when expressed relative to cholesterol. Similar results were obtained in plasma. While most studies did not show any difference in a-tocopherol between diabetic patients and control subjects [4] , a previous study also reported decreased a-tocopherolto-TG ratios, but unchanged a-tocopherol-to-total cholesterol ratios in LDL [36] . Although these results need to be confirmed in a larger population, the decrease of plasma and LDL a-tocopherol relative to TG in patients could be simply due to increased triglycerides levels in diabetic patients.
Altogether, our results show higher levels of lipid peroxidation markers in LDL from poorly controlled type 2 diabetic patients compared to control LDL. Since significant negative and positive correlations between HbA 1C % and plasmalogens and MDA, respectively, were observed, it can be then hypothesized that the increased nonenzymatic glycation of LDL, as assessed by HbA 1C , could have contributed to the increased non-enzymatic lipid peroxidation of LDL in patients [37] . The role of these modified parameters in the biological properties of oxidatively modified LDL in atherosclerosis still needs to be elucidated.
In conclusion, we show that isolation of LDL by UC is no more damaging than FPLC separation, as far as oxidative modification of lipids is concerned. We give new information on the baseline values of different and complementary lipid peroxides present in LDL from healthy subjects, which may serve as references to unravel lipid abnormalities in LDL from diabetic patients. We also show that increased lipid peroxidation is present in LDL from type-2 diabetic patients and may be evidenced by the measurement of hydroxylated fatty acids and PE plasmalogens.
